InvestorsHub Logo
Followers 49
Posts 1993
Boards Moderated 0
Alias Born 08/14/2019

Re: None

Friday, 07/10/2020 2:05:34 PM

Friday, July 10, 2020 2:05:34 PM

Post# of 54917
AMATEUR HOUR is over...........Understand how this SPACE works.....PRED HAS MANY IRONS IN THE FIRE!

ie; If you’re interested in or have experience in the biotech space, it should come as no surprise that biotech companies with little to no revenue can still be worth billions. Consider the most prominent 2017 biotech M&A deal when Gilead bought Kite Pharma for almost $12 billion. At the time of the deal, Kite was still loss-making, with over $600 million in accumulated deficit, but significantly, it also had a pipeline of CAR-T cell therapies, which treat cancer.

https://www.toptal.com/finance/valuation/biotech-valuation